GetTopicDetailResponse(id=6a0612463e96, topicName=GPR65, introduction=, content=B-ALL GPR65, image=null, comments=0, allHits=321, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Wed Feb 26 15:56:53 CST 2025, time=2025-02-26, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=501982, tagList=[TagDto(tagId=501982, tagName=GPR65)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2272000, encodeId=275f22e20003b, content=<a href='/topic/show?id=b99810e959b9' target=_blank style='color:#2F92EE;'>#CAR T細胞#</a> <a href='/topic/show?id=6a0612463e96' target=_blank style='color:#2F92EE;'>#GPR65#</a>, objectTitle=讀書報告 | 腫瘤細胞中GPR65失活通過巨噬細胞重塑CAR-T細胞耐藥性, objectType=article, longId=885190, objectId=fb5788519040, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/patient-meeting-a-doctor-PAYSRMZ.jpg, objectUrl=/article/show_article.do?id=fb5788519040, replyNumber=0, likeNumber=14, createdTime=2025-07-04, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fb5788519040, moduleTitle=讀書報告 | 腫瘤細胞中GPR65失活通過巨噬細胞重塑CAR-T細胞耐藥性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=fb5788519040)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2253709, encodeId=cdd12253e098a, content=<a href='/topic/show?id=18f43131be' target=_blank style='color:#2F92EE;'>#B-ALL#</a> <a href='/topic/show?id=6a0612463e96' target=_blank style='color:#2F92EE;'>#GPR65#</a>, objectTitle=Cancer Discov：于吉洋團隊揭示腫瘤細胞GPR65失活驅(qū)動CAR-T治療B型急淋白血病復(fù)發(fā)耐藥機制, objectType=article, longId=864212, objectId=5d9b8642123b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240513/1715588347041_5579292.jpg, objectUrl=/article/show_article.do?id=5d9b8642123b, replyNumber=0, likeNumber=35, createdTime=2025-02-26, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=5d9b8642123b, moduleTitle=Cancer Discov：于吉洋團隊揭示腫瘤細胞GPR65失活驅(qū)動CAR-T治療B型急淋白血病復(fù)發(fā)耐藥機制, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5d9b8642123b)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-02-26發(fā)表于陜西省
